Controls on clinical investigations in Europe: national differences

Area of Science:

• Medical device regulation
• European Union law
• Clinical research oversight

Background:

• Clinical investigations for non-CE-marked medical devices in Europe are governed by European Directives.
• National transposition of these Directives into law varies significantly across member states.
• This inconsistency poses regulatory challenges for medical device manufacturers.

Purpose of the Study:

• To examine the practical implications of differing national transpositions of European Directives for clinical investigations.
• To identify specific challenges faced by manufacturers due to these regulatory variations.
• To illustrate these differences using concrete case studies.

Main Methods:

• Comparative analysis of national laws transposing European Directives related to medical device clinical investigations.
• Presentation of two detailed case studies illustrating country-specific regulatory hurdles.
• Qualitative assessment of manufacturer experiences.

Main Results:

• Significant variations exist in the implementation of European Directives at the national level.
• Manufacturers encounter divergent requirements for clinical investigation approval and conduct.
• Case studies reveal specific procedural and legal obstacles in different European countries.

Conclusions:

• The lack of harmonized national implementation of European Directives complicates clinical investigations for non-CE-marked medical devices.
• Manufacturers require a thorough understanding of country-specific regulations to navigate investigations successfully.
• Further harmonization efforts are needed to streamline the regulatory landscape for medical devices in Europe.